References
M. Gibaldi and D. Perrier, “Pharmacokinetics,” (2nd ed.), Dekker, New York, pp 355–384, (1982).
K.J. Himmelstein and R.J. Lutz, A review of the applications of physiologically based pharmacokinetic modeling,J. Pharmacokinet. Biopharm. 7:127 (1979).
J.F. Young and F.F. Kadlubar, A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxylarylamine carcinogens as a function of urine pH, voiding interval, and resorption.Drug Metab. Dispos. 10:641 (1982).
R.L. Dedrick, Animal scale-up,J. Pharmacokinet. Biopharm. 1:435 (1973).
R.K. Jain, L.E. Gerlowski, J.M. Weissbrod, J. Wang, and R.N. Pierson, Kinetics of uptake, distribution and excretion of zinc in rats,Ann. Biomed. Eng. 9:347 (1981).
M.J. Angelo, K.B. Bischoff, A.B. Pritchard, and M.A. Presser, A physiological model for the pharmacokinetic s of methylene chloride in B6C3F1 mice following IV administration,J. Pharmacokinet. Biopharm. 12:413 (1984).
J. Gabrielsson, L. Paalzow, and L. Nordstrom, A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat,J. Pharmacokinet. Biopharm. 12:149 (1984).
J.L. Gabrielsson, P. Johansson, U. Bondesson, and L. Paalzow, Analysis of methadone disposition in the pregnant rat by means of a physiological flow model,J. Pharmacokinet. Biopharm. 13:355 (1985).
H. Harashima, Y. Sawada, Y. Sugiyama, T. Iga, and M. Hanano, Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics,J. Pharmacokinet. Biopharm. 13:425 (1985).
F.G. King, R.L. Dedrick, and F.F. Farris, Physiological pharmacokinetic modeling of cis-dichlorodiammine-platinum (II) (DDP) in several species,J. Pharmacokinet. Biopharm. 14:131 (1986).
F.G. King and R.L. Dedrick, Physiologic model for the pharmacokinetics of 2′ deoxycoformycin in normal and leukemic mice,J. Pharmacokinet. Biopharm. 9:519 (1981).
F.T. Lindstrom and D.S. Birkes, Estimation of population pharmacokinetic parameters using destructively obtained experimental data: A simulation study of the one-compartment model,Drug Metab. Dispos. 15:195 (1984).
M.E. Andersen, A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: analysis at steady-state,Toxicol. Appl. Pharmacol. 60:509 (1981).
K.C. Ng, Contributions to the computation of the matrix exponential, Report 212 of the Center for Pure and Applied Mathematics, University of California, Berkeley (1984).
B.N. Parlett, A recurrence among the elements of functions of triangular matrices,Lin. Alg. Appl. 14:117 (1976).
A.E. Adolph, Quantitative relations in the physiological constitutions of mammals,Science 109:579 (1949).
P.L. Altman and D.S. Dittmer, Table of Physiologic Constants, in: “Biology Data Handbook, Vol. 3,” Federation of American Societies for Experimental Biology, Bethesda, MD, pp. 1584, (1974).
C.M. Metzler, G.L. Elfring, and A.J. McEwen, “A User's Manual for NONLIN and Associated Programs,” The Upjohn Co., Kalamazoo, MI (1974).
S.R.B. Allerheiligen, T.M. Ludden, and R.F. Burk, The pharmacokinetics of pentane, a by-product of lipid peroxidation.Drug Metab. Dispos. 15:794 (1987).
S.R.B. Allerheiligen, T.M. Ludden, and R.F. Burk, Effect of clearance on the relationship between pulmonary excretion rate andin vivo production rate of volatile substances, in: “Simulation at the Frontiers of Science,” J. Young, V.W. Ingalls, and R. Hawkins, eds. Society for Computer Simulation, San Diego, p. 49, (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ludden, T.M., Allerheiligen, S.R.B. & Burk, R.F. Application of population analysis to physiological pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 19 (Suppl 3), S101–S113 (1991). https://doi.org/10.1007/BF01371012
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01371012